Jay Barth

Company: Lexeo Therapeutics

Job title: Chief Medical Officer

Seminars:

A Novel Gene Therapy Targeting APOE4 Associated Alzheimer’s Disease 11:30 am

The role of APOE in the pathogenesis of Alzheimer’s disease The basis of a gene therapy approach in APOE4-associated Alzheimer’s disease The Phase 1 clinical trial in APOE4 homozygotes with Alzheimer’s diseaseRead more

day: Day One: Track B AM